Pentoxifylline shortage — CA supply status & alternatives

Pentoxifylline

—

🇦🇺 AUST R 81197 · Clinect Pty Ltd

In supply · Australia

Pentoxifylline Sr

In supply · 🇦🇺 Australia · short in🇨🇦 CA

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Pentoxifylline
Brand names	Pentoxifylline Sr
Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper

Marketing-authorisation holders	NEURAXPHARM UK LIMITED, Clinect Pty Ltd, NCS HealthCare of KY, LLC dba Vangard Labs, APOTEX INC +3 more

Registrations on file	7

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Other markets

🇺🇸 US

US$0.24

Acquisition

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

5 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Moderate concentration risk

Tapi Nl BVHikal LTDSun Pharmaceutical Industries LTDZaklady Farmaceutyczne Polpharma SACspc Innovation Pharm CO LTD

Manufacturing countries: India, Poland · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders7 registrations · 7 MA holders

Product	Strength	Form	Market	MA holder	Status
PENTOXIFYLLINE 400 MG MODIFIED RELEASE TABLETS	400 MG	tablet	🇬🇧 GB	NEURAXPHARM UK LIMITED	Active
Trental	400mg	—	🇦🇺 AU	Clinect Pty Ltd	Active
Pentoxifylline	400mg/1	tablet	🇺🇸 US	NCS HealthCare of KY, LLC dba Vangard Labs	Active
Apo-Pentoxifylline Sr	—	tablet	🇨🇦 CA	APOTEX INC	Active
Jamp Pentoxifylline Sr	—	tablet	🇨🇦 CA	JAMP PHARMA CORPORATION	Active
Ratio-Pentoxifylline	—	tablet	🇨🇦 CA	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Active
Nu-Pentoxifylline-Sr	400 MG	tablet	🇨🇦 CA	NU-PHARM INC	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.